Combining a WT1 Vaccine (Galinpepimut-S) With Checkpoint Inhibition (Nivolumab) in Patients With WT1-Expressing Diffuse Pleural Mesothelioma: A Phase 1 Study.
- DOI
- 10.1016/j.jtocrr.2024.100756
- Published
- 2025 Jan
- Container
- JTO clinical and research reports
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jtocrr.2024.100756,
title = {Combining a WT1 Vaccine (Galinpepimut-S) With Checkpoint Inhibition (Nivolumab) in Patients With WT1-Expressing Diffuse Pleural Mesothelioma: A Phase 1 Study.},
author = {Agrawal P and Offin M and Lai V and Ginsberg MS and Adusumilli PS and Rusch VW and Sauter JL and Ho T and Wong P and Zauderer MG},
year = {2025},
journal = {JTO clinical and research reports},
doi = {10.1016/j.jtocrr.2024.100756},
url = {https://doi.org/10.1016/j.jtocrr.2024.100756}
}RIS
TY - JOUR TI - Combining a WT1 Vaccine (Galinpepimut-S) With Checkpoint Inhibition (Nivolumab) in Patients With WT1-Expressing Diffuse Pleural Mesothelioma: A Phase 1 Study. AU - Agrawal P AU - Offin M AU - Lai V AU - Ginsberg MS AU - Adusumilli PS AU - Rusch VW AU - Sauter JL AU - Ho T AU - Wong P AU - Zauderer MG PY - 2025 JO - JTO clinical and research reports DO - 10.1016/j.jtocrr.2024.100756 UR - https://doi.org/10.1016/j.jtocrr.2024.100756 ER -
APA
P, A., M, O., V, L., MS, G., PS, A., VW, R., JL, S., T, H., P, W., & MG, Z. (2025). Combining a WT1 Vaccine (Galinpepimut-S) With Checkpoint Inhibition (Nivolumab) in Patients With WT1-Expressing Diffuse Pleural Mesothelioma: A Phase 1 Study.. JTO clinical and research reports. https://doi.org/10.1016/j.jtocrr.2024.100756
Source records
- pubmed · retrieved 2026-09-25T20:06:10.005Z